Unicycive Therapeutics, Inc.

US$3.55As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:UNCYHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (32.22%)
Div yield —
ROE (101.07%)
Biotechnology
Beta (5Y) 1.86
PE TTM —
TSR TTM (25.26%)
Mkt cap US$98.89M
ROIC (58.51%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.45
(2.81%)
(46.54%)
Hold 1|7|5|12|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.04
0.05
0.05
0.06
26.79%
30.37%
36.93%
32.44%
Revenue$M
5.680
5.672
5.650
5.617
12.01%
7.36%
4.94%
2.75%
Peers (US$98.89M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.355
(1.544)
(1.324)
EBIT/Intx
1.655
0.074
0.067
Own earn%
34.22
(130.50)
(141.46)
Sh yield%
41.22
39.22
31.69
Owners
Insiders/Inst%
11.23
30.20
Short interest%
3.97
SBC / revenue%
1.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
24–31
$1 testx
—
Incr. ROIC%
4